Breast Cancer Imaging Market

Global Breast Cancer Imaging Market

The GMI Research forecasts that the Breast Cancer Imaging Market is witnessing an upsurge in demand over the forecast period. This is mainly due to the increasing prevalence of cancer and rising government initiatives to increase the screening and diagnostic rate.

Request a FREE Sample of Breast Cancer Imaging Market

Introduction of the Breast Cancer Imaging Market:

Breast cancer disease is the most common cancer impacting the female population across developed and emerging nations. In accordance with the American Cancer Society, breast cancer disease is the second most prominent cause of cancer-linked deaths in females across the world. In the United States, one in every eight women procures invasive breast cancer throughout her life expectancy.

Key Players of the Global Breast Cancer Imaging Market:

· Hologic Inc

· Siemens

· Fujifilm Holding Corporation

· Canon Inc

· Dilon Technologies

· GE Healthcare

· Philips

· Aurora Imaging Technology

· CMR Naviscan Corporation

· SonoCine Inc

Breast Cancer Imaging Market Dynamics (including market size, share, trends, forecast, growth, forecast, and industry analysis)

The global market for breast cancer imaging is forecasted to witness prominent growth during the forecast period. The market approximated a growth of USD 1,055 million in 2018 and is expected to touch USD 2,246 million by 2026, expanding at a rate of 8.5% during 2019-2026. Several crucial drivers responsible for the market's growth include the augmenting demand for technologically sophisticated products that allow superior precision, speed, and cost-efficiency, rising cases of patients with breast cancer, the establishment of customized implant products, and the growing occurrence of lifestyle-related diseases and disorders. , The United States, in 2019, contemplated witnessing 268,600 fresh cases of invasive cancer and 62,930 cases of non-invasive cancer. In addition, the technological modernizations in imaging devices followed by the initiation of several cancer screening programs by the government, which includes escalating reimbursement and insurance coverage, are some other factors strengthening the breast cancer imaging market size. Government agencies are recommending various tests for worldwide reimbursement.

Healthcare facilities such as hospitals, outpatient clinics, etc., that procure these expensive device systems often depend on third-party paymasters for compensation of costs induced in diagnosing and procedures operated with these device systems. However, it takes approximately two to five years for a system to guarantee indemnification once launched in the regional market. With the high cost of these systems and budget restrictions, healthcare facilities like hospitals are reluctant to disburse these technologically modernized systems. The imaging procedures are associated with specified risks. Imaging tests involve the discharge of high doses of fluorescent and barium contrast agents and radiation exposure in imaging and endoscopic procedures, which cause hazardous impacts such as nausea or diarrhea. The threat of ionizing radiation concerned with the implementation of CT, MRI, and X-rays, and the use of radioactive tracer injections in PET can inhibit the adoption of such screening procedures

Breast Cancer Imaging Market Segmentation:

Segmentation by Type

· Ionizing

· Non-Ionizing

Segmentation by End User

· Hospitals

· Diagnostic Centers

Segmentation by Region:

· North America

o United States of America

o Canada

· Asia Pacific

o China

o Japan

o India

o Rest of APAC

· Europe

o United Kingdom

o Germany

o France

o Spain

o Rest of Europe

· RoW

o Brazil

o South Africa

o Saudi Arabia

o UAE

o Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting company that offers business sights and market research reports for every enterprise, including small & medium enterprises and large organizations. Our research team helps the clients to understand the impact of market dynamics such as market size, share, drivers, growth opportunities, and other aspects. We have a team of analysts and industry experts who conduct market intelligence studies to ensure relevant and fact-based research across a wide range of sectors such as FMCG, Technology, Energy, Healthcare, and other industries. We collect relevant information about the industry using both internal and external databases. Our main focus is to keep our clients abridged of the emerging opportunities and challenges in a wide range of industries. We provide step-by-step assistance to our client through strategic and consulting services to reach a managerial and actionable decision. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping businesses stay ahead of the curve.

Media Contact

Company Name: GMI RESEARCH

Contact Person: Sarah Nash

Email: enquiry@gmiresearch.com

Phone: Europe – +353 1 442 8820; US – +1 860 881 2270

Address: Dublin, Ireland

Website: www.gmiresearch.com